Finasteride

    January 2004
    N. Levine Prof., C. C. Levine
    TLDR Finasteride helps treat male hair loss but may lower sex drive.
    Finasteride was a Type II 5 α-reductase inhibitor used primarily for treating androgenetic alopecia in men by reducing the conversion of testosterone to dihydrotestosterone in hair follicles. The recommended dosage for adult men was 1 mg taken orally daily, and it was not indicated for children. Common side effects included decreased libido, impotence, and decreased ejaculate volume, while no serious side effects were noted. It was contraindicated in individuals with hypersensitivity to the drug class or its components.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Related Research

    7 / 7 results